These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6411514)

  • 1. Tumor dependency of concanavalin A-induced potentiation of tumor cell immunogenicity.
    Kataoka T; Oh-hashi F; Akabori Y; Sakurai Y; Okabe M; Gomi K
    Gan; 1983 Jun; 74(3):412-8. PubMed ID: 6411514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and amplifier cell production by tumor vaccines enhanced by concanavalin A.
    Kataoka T; Oh-Hashi F; Sakurai Y
    Gan; 1982 Apr; 73(2):193-205. PubMed ID: 6811360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blastogenic potency of concanavalin-A-bound L1210 leukemic vaccine associated with its immunogenic activity.
    Kataoka T; Oh-hashi F; Sakurai Y
    Gan; 1979 Apr; 70(2):155-64. PubMed ID: 111995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of resistance to ascites tumor in mice with MFS-180 cells treated with glutaraldehyde, lipopolysaccharide, and concanavalin A.
    Nerkar DP; Chander R; Bandekar JR; Lewis NF
    Cancer Res; 1981 Jul; 41(7):2922-4. PubMed ID: 6788363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents.
    Kataoka T; Oh-hashi F; Sakurai Y; Gomi K
    Cancer Res; 1980 Oct; 40(10):3832-8. PubMed ID: 6254642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoprophylactic and immunotherapeutic response by concanavalin A-bound tumor vaccine enhanced by chemotherapeutic agents eliminating possible suppressors.
    Kataoka T; Ogihara K; Sakurai Y
    Cancer Res; 1980 Oct; 40(10):3839-45. PubMed ID: 6449286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A.
    Kataoka T; Oh-hashi F; Tsukagoshi S; Sakurai Y
    Cancer Res; 1977 Apr; 37(4):964-8. PubMed ID: 403001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of L1210 murine leukemia vaccine in vivo by levamisole.
    Kataoka T; Tsukagoshi S; Sakurai Y; Okabe M
    Gan; 1979 Aug; 70(4):515-9. PubMed ID: 510850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lectin potentiation of BCG-contact-mediated antitumor action.
    Poduval TB; Seshadri M; Sundaram K
    J Natl Cancer Inst; 1980 Nov; 65(5):909-12. PubMed ID: 6933260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapeutic response of concanavalin A-bound L1210 vaccine enhanced by a streptococcal immunopotentiator, OK-432.
    Kataoka T; Oh-hashi F; Sakurai Y
    Cancer Res; 1979 Jul; 39(7 Pt 1):2807-10. PubMed ID: 445486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant activity of the cell wall of Bifidobacterium infantis for in vivo immune responses in mice.
    Sekine K; Watanabe-Sekine E; Toida T; Kasashima T; Kataoka T; Hashimoto Y
    Immunopharmacol Immunotoxicol; 1994 Nov; 16(4):589-609. PubMed ID: 7876463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced induction of immune resistance by concanavalin A-bound L1210 vaccine and an immunopotentiator prepared from Coriolus versicolor.
    Kataoka T; Oh-hashi F; Tsukagoshi S; Sakurai Y
    Cancer Res; 1977 Dec; 37(12):4416-9. PubMed ID: 922733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitomycin C-augmented production of I-A antigen-positive macrophages in tumor vaccine-primed mice.
    Kataoka T; Yamamoto T; Honjo K; Murayama T
    Jpn J Cancer Res; 1986 Mar; 77(3):305-11. PubMed ID: 3009373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transplantability and immunogenicity in mice of lymphoma Nk/Ly cells modified by concanavalin A and neuraminidase].
    Bratus' GG; Darchuk GF
    Eksp Onkol; 1989; 11(3):35-8. PubMed ID: 2752940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
    Ogura T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the immunogenicity of hamster cells transformed by adenovirus and Herpes simplex virus.
    Thiry L; Sprecher-Goldberger S; Tack L; Jacques M; Stienon J
    Cancer Res; 1975 Apr; 35(4):1022-9. PubMed ID: 163694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine.
    Kataoka T; Akahori Y; Sakurai Y
    Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prolonged administration of low doses of dietary retinoids on cell-mediated immunity and the growth of transplantable tumors in mice.
    Forni G; Cerruti Sola S; Giovarelli M; Santoni A; Martinetto P; Vietti D
    J Natl Cancer Inst; 1986 Mar; 76(3):527-33. PubMed ID: 3081748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemo-immunotherapy of methylchoranthrene-induced fibrosarcoma by concanavalin A-bound tumor vaccine, levamisole and mitomycin C.
    Okabe M; Morimoto M; Marumo H
    J Pharmacobiodyn; 1982 Apr; 5(4):245-51. PubMed ID: 6811721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to lymphoid tumors in syngeneic mice by immunization with mitomycin C-treated cells.
    Benjamini E; Fong S; Erickson C; Leung CY; Rennick D; Scibienski RJ
    J Immunol; 1977 Feb; 118(2):685-93. PubMed ID: 839074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.